Review




Structured Review

Shanghai GenePharma sgrna sequences fbxw7β
a Transfection efficiency of HN6 and CAL27 NOTCH1 C1133Y and WT cells determined by real-time qPCR. b Growth curves of NOTCH1 WT -transfected cells (blue lines), NOTCH1 C1133Y -transfected cells (red lines) and control cells (black lines). The NOTCH1 C1133Y -transfected cells had higher proliferation rates compared with the NOTCH1 WT -transfected cells. c Colony formation assays were performed for 2 week in six-well cell culture cluster in HN6 and CAL27 stable transfected cells. d NOTCH1 C1133Y - transfected cells presented a significantly lower percentage of G1 phase and higher ratio of S phase than NOTCH1 WT cells. e , f Wound healing and Transwell assays were employed to analyze the cell migration and invasion ability. NOTCH1 C1133Y -transfected cells exhibited higher metastatic ability in HN6 and CAL27 cell lines compared with NOTCH1 WT -transfected cells. g mRNA expression levels of three isoforms of FBXW7 (relative to GAPDH) after transfection of NOTCH1 C1133Y or NOTCH1 WT in HN6 and CAL27 cells. <t>FBXW7β</t> mRNA was greatly reduced in NOTCH1 C1133Y transfected cells compared to FBXW7α or FBXW7γ mRNA levels. h Left panel, the band of FBXW7 were detected by western blot after transfection of three individual isoform plasmids. Right panel, the alteration of FBXW7β protein levels in NOTCH1 C1133Y overexpressed cells. Data are mean ± SD from three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001.
Sgrna Sequences Fbxw7β, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+sequence/sgrna+sequences+fbxw7%CE%B2/pmc07426429-97-4-8
Average 90 stars, based on 1 article reviews
sgrna sequences fbxw7β - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma"

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma

Journal: Cell Death & Disease

doi: 10.1038/s41419-020-02873-4

a Transfection efficiency of HN6 and CAL27 NOTCH1 C1133Y and WT cells determined by real-time qPCR. b Growth curves of NOTCH1 WT -transfected cells (blue lines), NOTCH1 C1133Y -transfected cells (red lines) and control cells (black lines). The NOTCH1 C1133Y -transfected cells had higher proliferation rates compared with the NOTCH1 WT -transfected cells. c Colony formation assays were performed for 2 week in six-well cell culture cluster in HN6 and CAL27 stable transfected cells. d NOTCH1 C1133Y - transfected cells presented a significantly lower percentage of G1 phase and higher ratio of S phase than NOTCH1 WT cells. e , f Wound healing and Transwell assays were employed to analyze the cell migration and invasion ability. NOTCH1 C1133Y -transfected cells exhibited higher metastatic ability in HN6 and CAL27 cell lines compared with NOTCH1 WT -transfected cells. g mRNA expression levels of three isoforms of FBXW7 (relative to GAPDH) after transfection of NOTCH1 C1133Y or NOTCH1 WT in HN6 and CAL27 cells. FBXW7β mRNA was greatly reduced in NOTCH1 C1133Y transfected cells compared to FBXW7α or FBXW7γ mRNA levels. h Left panel, the band of FBXW7 were detected by western blot after transfection of three individual isoform plasmids. Right panel, the alteration of FBXW7β protein levels in NOTCH1 C1133Y overexpressed cells. Data are mean ± SD from three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure Legend Snippet: a Transfection efficiency of HN6 and CAL27 NOTCH1 C1133Y and WT cells determined by real-time qPCR. b Growth curves of NOTCH1 WT -transfected cells (blue lines), NOTCH1 C1133Y -transfected cells (red lines) and control cells (black lines). The NOTCH1 C1133Y -transfected cells had higher proliferation rates compared with the NOTCH1 WT -transfected cells. c Colony formation assays were performed for 2 week in six-well cell culture cluster in HN6 and CAL27 stable transfected cells. d NOTCH1 C1133Y - transfected cells presented a significantly lower percentage of G1 phase and higher ratio of S phase than NOTCH1 WT cells. e , f Wound healing and Transwell assays were employed to analyze the cell migration and invasion ability. NOTCH1 C1133Y -transfected cells exhibited higher metastatic ability in HN6 and CAL27 cell lines compared with NOTCH1 WT -transfected cells. g mRNA expression levels of three isoforms of FBXW7 (relative to GAPDH) after transfection of NOTCH1 C1133Y or NOTCH1 WT in HN6 and CAL27 cells. FBXW7β mRNA was greatly reduced in NOTCH1 C1133Y transfected cells compared to FBXW7α or FBXW7γ mRNA levels. h Left panel, the band of FBXW7 were detected by western blot after transfection of three individual isoform plasmids. Right panel, the alteration of FBXW7β protein levels in NOTCH1 C1133Y overexpressed cells. Data are mean ± SD from three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001.

Techniques Used: Transfection, Cell Culture, Migration, Expressing, Western Blot

a The subcellular location of NOTCH1 receptors in CAL27 cells was assessed by immunofluorescence. The NOTCH1-FITC staining revealed that NOTCH1 protein in C1133Y-mutated cells was only localized in the cytoplasm. Costaining of NOTCH1 with ER-marker Calnexin showed strong overlapped staining in NOTCH1 C1133Y -transfected cells. FBXW7β-EGFP staining was present in the microsomal fraction together with the ER-resident protein Calnexin. Scale bar, 20 μm. b The localization of NOTCH1 or FBXW7β in cytoplasm or nucleus was assessed in 100 cells, and the percent of cells was shown. The data indicated that 79.3% of NOTCH1 C1133Y -transfected cells and 85.3% of FBXW7β-transfected cells exhibited cytoplasmic expression, but that only 54% of NOTCH1 WT -transfected cells exhibited cell cytoplasmic expression. c Overlapped staining of NOTCH1 or FBXW7β with ER-marker Calnexin was counted in NOTCH1 C1133Y and NOTCH1 WT or FBXW7β transfected cells. In all, 82.8% of NOTCH1 C1133Y -transfected cells and 91.2% of FBXW7β-transfected cells showed overlap between FITC (NOTCH1 or FBXW7β staining) and CY3 (Calnexin staining), while 50.5% of NOTCH1 WT -transfected cells showed overlapped staining between NOTCH1 and Calnexin. Data are mean ± SD. Percentages of localization were calculated from three independent experiments. ** p < 0.01, *** p < 0.001.
Figure Legend Snippet: a The subcellular location of NOTCH1 receptors in CAL27 cells was assessed by immunofluorescence. The NOTCH1-FITC staining revealed that NOTCH1 protein in C1133Y-mutated cells was only localized in the cytoplasm. Costaining of NOTCH1 with ER-marker Calnexin showed strong overlapped staining in NOTCH1 C1133Y -transfected cells. FBXW7β-EGFP staining was present in the microsomal fraction together with the ER-resident protein Calnexin. Scale bar, 20 μm. b The localization of NOTCH1 or FBXW7β in cytoplasm or nucleus was assessed in 100 cells, and the percent of cells was shown. The data indicated that 79.3% of NOTCH1 C1133Y -transfected cells and 85.3% of FBXW7β-transfected cells exhibited cytoplasmic expression, but that only 54% of NOTCH1 WT -transfected cells exhibited cell cytoplasmic expression. c Overlapped staining of NOTCH1 or FBXW7β with ER-marker Calnexin was counted in NOTCH1 C1133Y and NOTCH1 WT or FBXW7β transfected cells. In all, 82.8% of NOTCH1 C1133Y -transfected cells and 91.2% of FBXW7β-transfected cells showed overlap between FITC (NOTCH1 or FBXW7β staining) and CY3 (Calnexin staining), while 50.5% of NOTCH1 WT -transfected cells showed overlapped staining between NOTCH1 and Calnexin. Data are mean ± SD. Percentages of localization were calculated from three independent experiments. ** p < 0.01, *** p < 0.001.

Techniques Used: Immunofluorescence, Staining, Marker, Transfection, Expressing

a Fold change of FBXW7β mRNA levels in 30 paired OSCC tissues. b Fold change of FBXW7β protein expression levels in eight OSCC tissues and two nontumor tissues. c Relative FBXW7β mRNA and protein levels in five OSCC cell lines and one normal oral epithelial cell line (HOK). d qRT-PCR detection after transfection of PEGFP-N1-FBXW7α or PEGFP-N1-FBXW7β or PEGFP-N1-FBXW7γ and empty vector in HN6 and CAL27 cells. e – g Wound healing ( e ), Transwell ( f ), and CCK-8 ( g ) assays were employed to analyze the cell migration, invasion, and proliferation ability. Compared with other two subtypes, overexpression of FBXW7β significantly reduced cell growth, migration, and invasion. Data are mean ± SD from three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure Legend Snippet: a Fold change of FBXW7β mRNA levels in 30 paired OSCC tissues. b Fold change of FBXW7β protein expression levels in eight OSCC tissues and two nontumor tissues. c Relative FBXW7β mRNA and protein levels in five OSCC cell lines and one normal oral epithelial cell line (HOK). d qRT-PCR detection after transfection of PEGFP-N1-FBXW7α or PEGFP-N1-FBXW7β or PEGFP-N1-FBXW7γ and empty vector in HN6 and CAL27 cells. e – g Wound healing ( e ), Transwell ( f ), and CCK-8 ( g ) assays were employed to analyze the cell migration, invasion, and proliferation ability. Compared with other two subtypes, overexpression of FBXW7β significantly reduced cell growth, migration, and invasion. Data are mean ± SD from three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001.

Techniques Used: Expressing, Quantitative RT-PCR, Transfection, Plasmid Preparation, CCK-8 Assay, Migration, Over Expression

a Flow cytometry analysis showed cell cycle arrest due to FBXW7β transfection (left panel). Proteins related to cell cycle progression were demonstrated (middle and right panel). FBXW7β overexpression resulted in the decreased expression levels of cell cycle related proteins. b FBXW7β-sgRNA dramatically increased the number of colonies (left panel) and cell growth (right panel). c , d Depleting FBXW7β potently promoted cell migration ( c ) and invasion ( d ). Data are mean ± SD from three independent experiments. e The tumors dissected from mice ( n = 6 for each group) were presented. f – h Evaluation on tumor incidence ( f ), weight ( g ), and size ( h ). All the results were shown as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure Legend Snippet: a Flow cytometry analysis showed cell cycle arrest due to FBXW7β transfection (left panel). Proteins related to cell cycle progression were demonstrated (middle and right panel). FBXW7β overexpression resulted in the decreased expression levels of cell cycle related proteins. b FBXW7β-sgRNA dramatically increased the number of colonies (left panel) and cell growth (right panel). c , d Depleting FBXW7β potently promoted cell migration ( c ) and invasion ( d ). Data are mean ± SD from three independent experiments. e The tumors dissected from mice ( n = 6 for each group) were presented. f – h Evaluation on tumor incidence ( f ), weight ( g ), and size ( h ). All the results were shown as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.

Techniques Used: Flow Cytometry, Transfection, Over Expression, Expressing, Migration

a , b Western blotting was used to detect the expression levels of NOTCH1 and FBXW7β. The overexpression of NOTCH1 C1133Y decreased FBXW7β expression, whereas the upregulation of FBXW7β attenuated the loss of FBXW7β expression in NOTCH1 C1133Y overexpressed HN6 and CAL27 cells. c CCK-8 assay showed that upregulation of NOTCH1 C1133Y dramatically increased the cell proliferation ability in HN6 and CAL27 cells. d Transwell assay showed that the upregulation of FBXW7β significantly reduced the cell invasion in NOTCH1 C1133Y transfected cells. Data are mean ± SD from three independent experiments. e The tumors dissected from mice were presented ( n = 6 for each group). From top to bottom, each line of tumors represented: FBXW7β, NOTCH1 C1133Y , FBXW7β+ NOTCH1 C1133Y , and NC. f – h Evaluation on tumor incidence, weight, and size. All the results were shown as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure Legend Snippet: a , b Western blotting was used to detect the expression levels of NOTCH1 and FBXW7β. The overexpression of NOTCH1 C1133Y decreased FBXW7β expression, whereas the upregulation of FBXW7β attenuated the loss of FBXW7β expression in NOTCH1 C1133Y overexpressed HN6 and CAL27 cells. c CCK-8 assay showed that upregulation of NOTCH1 C1133Y dramatically increased the cell proliferation ability in HN6 and CAL27 cells. d Transwell assay showed that the upregulation of FBXW7β significantly reduced the cell invasion in NOTCH1 C1133Y transfected cells. Data are mean ± SD from three independent experiments. e The tumors dissected from mice were presented ( n = 6 for each group). From top to bottom, each line of tumors represented: FBXW7β, NOTCH1 C1133Y , FBXW7β+ NOTCH1 C1133Y , and NC. f – h Evaluation on tumor incidence, weight, and size. All the results were shown as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.

Techniques Used: Western Blot, Expressing, Over Expression, CCK-8 Assay, Transwell Assay, Transfection

a , b AKT/ERK/NFκB signaling activities were evaluated by western blot analysis in HN6 ( a ) and CAL27 cells ( b ). The gray values of images demonstrated that FBXW7β transfection decreased phosphorylation of AKT/ERK/NFκB and reversed the NOTCH1 C1133Y -induced activation of AKT/ERK/NFκB phosphorylation. c , d Overexpression of FBXW7β reversed the increased protein expression levels of EMT markers and prevented the decrease in E-cadherin and β-Catenin caused by NOTCH1 C1133Y in HN6 ( c ) and CAL27 ( d ) cells. e The expression of p-AKT, p-ERK, and p-NFκB in xenografted mice was ascertained using IHC assay on tumor sections. The percentages of positive cells were acquired from three separate images and the qualification was presented. Scale bar, 20 μm. All the results were shown as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure Legend Snippet: a , b AKT/ERK/NFκB signaling activities were evaluated by western blot analysis in HN6 ( a ) and CAL27 cells ( b ). The gray values of images demonstrated that FBXW7β transfection decreased phosphorylation of AKT/ERK/NFκB and reversed the NOTCH1 C1133Y -induced activation of AKT/ERK/NFκB phosphorylation. c , d Overexpression of FBXW7β reversed the increased protein expression levels of EMT markers and prevented the decrease in E-cadherin and β-Catenin caused by NOTCH1 C1133Y in HN6 ( c ) and CAL27 ( d ) cells. e The expression of p-AKT, p-ERK, and p-NFκB in xenografted mice was ascertained using IHC assay on tumor sections. The percentages of positive cells were acquired from three separate images and the qualification was presented. Scale bar, 20 μm. All the results were shown as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.

Techniques Used: Western Blot, Transfection, Activation Assay, Over Expression, Expressing

a HN6 and CAL27 NOTCH1 C1133Y -transfected cells were treated with MG132 (10 μM) for the indicated times, and then the levels of NOTCH1 were detected. b The cells were subjected to cycloheximide (CHX) (20 μM) exposure at the indicated times, and the protein expression levels of NOTCH1 were verified. c Co-IP between NOTCH1 C1133Y and ubiquitin in HN6 and CAL27 cells. d Co-IP experiment showed that NOTCH1 C1133Y could be co-precipitated together with FBXW7β. HN6 or CAL27 cells were transfected with NOTCH1 C1133Y , NOTCH1 WT , or NC plasmids and precipitated with NOTCH1 antibody. IgG group presented the lysates of cells transfected with NOTCH1 C1133Y were precipitated with igG, which represented the negative control. e Detection of the effects of NOTCH1 C1133Y on FBXW7β expression, either with or without CHX (20 μM) in HN6 and CAL27 cells. f Ectopic dose-dependent effect of NOTCH1 C1133Y overexpression caused a significant reduction of endogenous FBXW7β proteins. g Co-IP experiment showed MG-132 promoted the binding level of NOTCH1 and FBXW7β. The cells in NOTCH1 C1133Y groups were treated with or without proteasomal inhibitor MG132 (10 μM). Cell lysates were prepared and subjected to immunoprecipitation with anti-GFP antibody. The level of FBXW7β was detected by western blotting analysis. Data are mean ± SD from three independent experiments. *** p < 0.001.
Figure Legend Snippet: a HN6 and CAL27 NOTCH1 C1133Y -transfected cells were treated with MG132 (10 μM) for the indicated times, and then the levels of NOTCH1 were detected. b The cells were subjected to cycloheximide (CHX) (20 μM) exposure at the indicated times, and the protein expression levels of NOTCH1 were verified. c Co-IP between NOTCH1 C1133Y and ubiquitin in HN6 and CAL27 cells. d Co-IP experiment showed that NOTCH1 C1133Y could be co-precipitated together with FBXW7β. HN6 or CAL27 cells were transfected with NOTCH1 C1133Y , NOTCH1 WT , or NC plasmids and precipitated with NOTCH1 antibody. IgG group presented the lysates of cells transfected with NOTCH1 C1133Y were precipitated with igG, which represented the negative control. e Detection of the effects of NOTCH1 C1133Y on FBXW7β expression, either with or without CHX (20 μM) in HN6 and CAL27 cells. f Ectopic dose-dependent effect of NOTCH1 C1133Y overexpression caused a significant reduction of endogenous FBXW7β proteins. g Co-IP experiment showed MG-132 promoted the binding level of NOTCH1 and FBXW7β. The cells in NOTCH1 C1133Y groups were treated with or without proteasomal inhibitor MG132 (10 μM). Cell lysates were prepared and subjected to immunoprecipitation with anti-GFP antibody. The level of FBXW7β was detected by western blotting analysis. Data are mean ± SD from three independent experiments. *** p < 0.001.

Techniques Used: Transfection, Expressing, Co-Immunoprecipitation Assay, Negative Control, Over Expression, Binding Assay, Immunoprecipitation, Western Blot

Related Articles

Transfection:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Cell Culture:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Migration:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Expressing:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Western Blot:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Immunofluorescence:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Staining:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Marker:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Quantitative RT-PCR:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Plasmid Preparation:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

CCK-8 Assay:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Over Expression:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Flow Cytometry:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Transwell Assay:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Activation Assay:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Co-Immunoprecipitation Assay:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Negative Control:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Binding Assay:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and

Immunoprecipitation:

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′- CTGAGGTCCCCAAAAGTTGT-3′; and

Article Title: Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Article Snippet: sgRNA oligomers were produced and cloned into the pU6gRNACas9EGFP vector. .. The sgRNA sequences of FBXW7β were made by Shanghai Genepharma (Shanghai, China). .. The sgRNA sequences were as follows: sgRNA1: 5′-CTGAGGTCCCCAAAAGTTGT-3′; and



Similar Products

96
Addgene inc sgrna sequences targeting trmt6
Sgrna Sequences Targeting Trmt6, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+sequence/lentiCRISPR+v2+(Plasmid+%2352961)/10__1186_slash_s40170___026___00452___3-88-0-13
Average 96 stars, based on 1 article reviews
sgrna sequences targeting trmt6 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

86
Sangon Biotech sgrna sequences
Sgrna Sequences, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+sequence/sequences+sirna/pm42296148-160-11-26
Average 86 stars, based on 1 article reviews
sgrna sequences - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Sangon Biotech sgrna dna oligo sequences
Sgrna Dna Oligo Sequences, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+sequence/dna+sequences/pm42288521-471-1-9
Average 86 stars, based on 1 article reviews
sgrna dna oligo sequences - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

99
Plasmidsaurus sgrna sequences
( A ) Schematic of the Cre-dependent <t>AAV-CMV-DIO-SaCas9-U6-sgRNA</t> vector. ( B ) sgRNA target site within the Rosa26 locus, showing the sgRNA target sequence (red) and PAM sequence (blue); sgRNA target sequence is anti-sense relative to the gene coding sequence. ( C ) Representative sanger sequencing traces from Cre- and Cre+ samples, with the expected SaCas9 cut site indicated (arrow). ( D ) In vitro validation workflow. NIH/3T3 cells were co-transfected with AAV-CMV-DIO-SaCas9-U6-Rosa26 sgRNA and AAV-Ef1a-mCherry-IRES-Cre. mCherry-positive cells isolated by FACS and analyzed by amplicon sequencing. ( E ) Pie chart showing average indel frequency (wild-type, <t>deletion,</t> <t>insertion),</t> with individual sample editing efficiencies shown below. ( F ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertion length in base pairs. ( G ) In vivo validation workflow. DAT-Cre mice were co-injected with AAV-DIO-KASH-EGFP and AAV-DIO-SaCas9-U6-Rosa26 sgRNA. ( H ) Pie chart showing the average indel frequency, with individual sample editing efficiencies shown below. ( I ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertions (bp).
Sgrna Sequences, supplied by Plasmidsaurus, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+sequence/RNA-Seq/bio_rxiv__64898__2026__06__03__730017-144-3-10
Average 99 stars, based on 1 article reviews
sgrna sequences - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

86
Benchling Inc optimal single guide rna sgrna target sequences
( A ) Schematic of the Cre-dependent <t>AAV-CMV-DIO-SaCas9-U6-sgRNA</t> vector. ( B ) sgRNA target site within the Rosa26 locus, showing the sgRNA target sequence (red) and PAM sequence (blue); sgRNA target sequence is anti-sense relative to the gene coding sequence. ( C ) Representative sanger sequencing traces from Cre- and Cre+ samples, with the expected SaCas9 cut site indicated (arrow). ( D ) In vitro validation workflow. NIH/3T3 cells were co-transfected with AAV-CMV-DIO-SaCas9-U6-Rosa26 sgRNA and AAV-Ef1a-mCherry-IRES-Cre. mCherry-positive cells isolated by FACS and analyzed by amplicon sequencing. ( E ) Pie chart showing average indel frequency (wild-type, <t>deletion,</t> <t>insertion),</t> with individual sample editing efficiencies shown below. ( F ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertion length in base pairs. ( G ) In vivo validation workflow. DAT-Cre mice were co-injected with AAV-DIO-KASH-EGFP and AAV-DIO-SaCas9-U6-Rosa26 sgRNA. ( H ) Pie chart showing the average indel frequency, with individual sample editing efficiencies shown below. ( I ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertions (bp).
Optimal Single Guide Rna Sgrna Target Sequences, supplied by Benchling Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+sequence/guide+rna/pm42167230-305-5-14
Average 86 stars, based on 1 article reviews
optimal single guide rna sgrna target sequences - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Sangon Biotech sgrnas sequence
( A ) Schematic of the Cre-dependent <t>AAV-CMV-DIO-SaCas9-U6-sgRNA</t> vector. ( B ) sgRNA target site within the Rosa26 locus, showing the sgRNA target sequence (red) and PAM sequence (blue); sgRNA target sequence is anti-sense relative to the gene coding sequence. ( C ) Representative sanger sequencing traces from Cre- and Cre+ samples, with the expected SaCas9 cut site indicated (arrow). ( D ) In vitro validation workflow. NIH/3T3 cells were co-transfected with AAV-CMV-DIO-SaCas9-U6-Rosa26 sgRNA and AAV-Ef1a-mCherry-IRES-Cre. mCherry-positive cells isolated by FACS and analyzed by amplicon sequencing. ( E ) Pie chart showing average indel frequency (wild-type, <t>deletion,</t> <t>insertion),</t> with individual sample editing efficiencies shown below. ( F ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertion length in base pairs. ( G ) In vivo validation workflow. DAT-Cre mice were co-injected with AAV-DIO-KASH-EGFP and AAV-DIO-SaCas9-U6-Rosa26 sgRNA. ( H ) Pie chart showing the average indel frequency, with individual sample editing efficiencies shown below. ( I ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertions (bp).
Sgrnas Sequence, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+sequence/sequence+sgrnas/pm42126774-40-5-16
Average 86 stars, based on 1 article reviews
sgrnas sequence - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Applied Biological Materials Inc sgrna sequences
( A ) Schematic of the Cre-dependent <t>AAV-CMV-DIO-SaCas9-U6-sgRNA</t> vector. ( B ) sgRNA target site within the Rosa26 locus, showing the sgRNA target sequence (red) and PAM sequence (blue); sgRNA target sequence is anti-sense relative to the gene coding sequence. ( C ) Representative sanger sequencing traces from Cre- and Cre+ samples, with the expected SaCas9 cut site indicated (arrow). ( D ) In vitro validation workflow. NIH/3T3 cells were co-transfected with AAV-CMV-DIO-SaCas9-U6-Rosa26 sgRNA and AAV-Ef1a-mCherry-IRES-Cre. mCherry-positive cells isolated by FACS and analyzed by amplicon sequencing. ( E ) Pie chart showing average indel frequency (wild-type, <t>deletion,</t> <t>insertion),</t> with individual sample editing efficiencies shown below. ( F ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertion length in base pairs. ( G ) In vivo validation workflow. DAT-Cre mice were co-injected with AAV-DIO-KASH-EGFP and AAV-DIO-SaCas9-U6-Rosa26 sgRNA. ( H ) Pie chart showing the average indel frequency, with individual sample editing efficiencies shown below. ( I ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertions (bp).
Sgrna Sequences, supplied by Applied Biological Materials Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+sequence/sequences+sgrna/pm42105746-640-13-41
Average 86 stars, based on 1 article reviews
sgrna sequences - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Novogen Inc sgrna sequencing
( A ) Schematic of the Cre-dependent <t>AAV-CMV-DIO-SaCas9-U6-sgRNA</t> vector. ( B ) sgRNA target site within the Rosa26 locus, showing the sgRNA target sequence (red) and PAM sequence (blue); sgRNA target sequence is anti-sense relative to the gene coding sequence. ( C ) Representative sanger sequencing traces from Cre- and Cre+ samples, with the expected SaCas9 cut site indicated (arrow). ( D ) In vitro validation workflow. NIH/3T3 cells were co-transfected with AAV-CMV-DIO-SaCas9-U6-Rosa26 sgRNA and AAV-Ef1a-mCherry-IRES-Cre. mCherry-positive cells isolated by FACS and analyzed by amplicon sequencing. ( E ) Pie chart showing average indel frequency (wild-type, <t>deletion,</t> <t>insertion),</t> with individual sample editing efficiencies shown below. ( F ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertion length in base pairs. ( G ) In vivo validation workflow. DAT-Cre mice were co-injected with AAV-DIO-KASH-EGFP and AAV-DIO-SaCas9-U6-Rosa26 sgRNA. ( H ) Pie chart showing the average indel frequency, with individual sample editing efficiencies shown below. ( I ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertions (bp).
Sgrna Sequencing, supplied by Novogen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+sequence/sequencing+sgrna/pm42086580-186-21-26
Average 86 stars, based on 1 article reviews
sgrna sequencing - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Synthego Inc single guide rna sgrna sequences targeting fh
( A ) Schematic of the Cre-dependent <t>AAV-CMV-DIO-SaCas9-U6-sgRNA</t> vector. ( B ) sgRNA target site within the Rosa26 locus, showing the sgRNA target sequence (red) and PAM sequence (blue); sgRNA target sequence is anti-sense relative to the gene coding sequence. ( C ) Representative sanger sequencing traces from Cre- and Cre+ samples, with the expected SaCas9 cut site indicated (arrow). ( D ) In vitro validation workflow. NIH/3T3 cells were co-transfected with AAV-CMV-DIO-SaCas9-U6-Rosa26 sgRNA and AAV-Ef1a-mCherry-IRES-Cre. mCherry-positive cells isolated by FACS and analyzed by amplicon sequencing. ( E ) Pie chart showing average indel frequency (wild-type, <t>deletion,</t> <t>insertion),</t> with individual sample editing efficiencies shown below. ( F ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertion length in base pairs. ( G ) In vivo validation workflow. DAT-Cre mice were co-injected with AAV-DIO-KASH-EGFP and AAV-DIO-SaCas9-U6-Rosa26 sgRNA. ( H ) Pie chart showing the average indel frequency, with individual sample editing efficiencies shown below. ( I ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertions (bp).
Single Guide Rna Sgrna Sequences Targeting Fh, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+sequence/sequences+sgrna/pm42082831-318-1-9
Average 86 stars, based on 1 article reviews
single guide rna sgrna sequences targeting fh - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Synthego Inc sgrna sequences
( A ) Schematic of the Cre-dependent <t>AAV-CMV-DIO-SaCas9-U6-sgRNA</t> vector. ( B ) sgRNA target site within the Rosa26 locus, showing the sgRNA target sequence (red) and PAM sequence (blue); sgRNA target sequence is anti-sense relative to the gene coding sequence. ( C ) Representative sanger sequencing traces from Cre- and Cre+ samples, with the expected SaCas9 cut site indicated (arrow). ( D ) In vitro validation workflow. NIH/3T3 cells were co-transfected with AAV-CMV-DIO-SaCas9-U6-Rosa26 sgRNA and AAV-Ef1a-mCherry-IRES-Cre. mCherry-positive cells isolated by FACS and analyzed by amplicon sequencing. ( E ) Pie chart showing average indel frequency (wild-type, <t>deletion,</t> <t>insertion),</t> with individual sample editing efficiencies shown below. ( F ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertion length in base pairs. ( G ) In vivo validation workflow. DAT-Cre mice were co-injected with AAV-DIO-KASH-EGFP and AAV-DIO-SaCas9-U6-Rosa26 sgRNA. ( H ) Pie chart showing the average indel frequency, with individual sample editing efficiencies shown below. ( I ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertions (bp).
Sgrna Sequences, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+sequence/sgrna/pmc13136223-232-13-37
Average 86 stars, based on 1 article reviews
sgrna sequences - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


( A ) Schematic of the Cre-dependent AAV-CMV-DIO-SaCas9-U6-sgRNA vector. ( B ) sgRNA target site within the Rosa26 locus, showing the sgRNA target sequence (red) and PAM sequence (blue); sgRNA target sequence is anti-sense relative to the gene coding sequence. ( C ) Representative sanger sequencing traces from Cre- and Cre+ samples, with the expected SaCas9 cut site indicated (arrow). ( D ) In vitro validation workflow. NIH/3T3 cells were co-transfected with AAV-CMV-DIO-SaCas9-U6-Rosa26 sgRNA and AAV-Ef1a-mCherry-IRES-Cre. mCherry-positive cells isolated by FACS and analyzed by amplicon sequencing. ( E ) Pie chart showing average indel frequency (wild-type, deletion, insertion), with individual sample editing efficiencies shown below. ( F ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertion length in base pairs. ( G ) In vivo validation workflow. DAT-Cre mice were co-injected with AAV-DIO-KASH-EGFP and AAV-DIO-SaCas9-U6-Rosa26 sgRNA. ( H ) Pie chart showing the average indel frequency, with individual sample editing efficiencies shown below. ( I ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertions (bp).

Journal: bioRxiv

Article Title: Cell-type targeted CRISPR/Cas9 Clock knockdown in mouse VTA dopamine neurons alter sleep, behavior, and cellular excitability

doi: 10.64898/2026.06.03.730017

Figure Lengend Snippet: ( A ) Schematic of the Cre-dependent AAV-CMV-DIO-SaCas9-U6-sgRNA vector. ( B ) sgRNA target site within the Rosa26 locus, showing the sgRNA target sequence (red) and PAM sequence (blue); sgRNA target sequence is anti-sense relative to the gene coding sequence. ( C ) Representative sanger sequencing traces from Cre- and Cre+ samples, with the expected SaCas9 cut site indicated (arrow). ( D ) In vitro validation workflow. NIH/3T3 cells were co-transfected with AAV-CMV-DIO-SaCas9-U6-Rosa26 sgRNA and AAV-Ef1a-mCherry-IRES-Cre. mCherry-positive cells isolated by FACS and analyzed by amplicon sequencing. ( E ) Pie chart showing average indel frequency (wild-type, deletion, insertion), with individual sample editing efficiencies shown below. ( F ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertion length in base pairs. ( G ) In vivo validation workflow. DAT-Cre mice were co-injected with AAV-DIO-KASH-EGFP and AAV-DIO-SaCas9-U6-Rosa26 sgRNA. ( H ) Pie chart showing the average indel frequency, with individual sample editing efficiencies shown below. ( I ) Bar graph showing average distribution of indel sizes, grouped by deletion and insertions (bp).

Article Snippet: Correct insertion of sgRNA sequences was confirmed by Sanger sequencing (Plasmidsaurus).

Techniques: Plasmid Preparation, Sequencing, In Vitro, Biomarker Discovery, Transfection, Isolation, Amplification, In Vivo, Injection

(A) Mouse clock gene structure with sgRNA target sites in Exons 9, 10, and 16; sgRNA (blue) and PAM (red) sequences indicated. sgRNA target sequence is anti-sense relative to the gene coding sequence. Sanger traces from GFP+ nuclei confirm editing at each site; GFP- traces not shown. ( B-D ) Indel distributions for Clock sgRNAs #1-#3 from in vivo virally-transduced nuclei as pie charts and scatter plots of individual editing efficiencies. sgRNA #3 achieved 69% editing efficiency. ( E ) In situ hybridization quantifying Clock mRNA in Cas9-expressing VTA neurons. ( F ) Representative fluorescence images for Cas9 (green), DAT (red) and Clock (cyan). Scale bar = 100 μm. ( G ) Violin plot quantifying Clock mRNA levels in Cas9-expressing cells. Clock-targeted sgRNA significantly reduced mRNA relative to Rosa26 control. ( H ) Experimental design for immunohistochemistry (IHC). Virus expressing Cas9 and sgRNAs targeting Clock (C3 or C2+3) was injected at different titers (low: 5 × 10¹¹, high: 5 × 10¹²). After 4 weeks, brain sections were processed for IHC. (I ) Representative IHC images showing Clock (red), and HA-tag (Cas9+, magenta). Scale bar = 100 μm. ( J ) Clock intensity in HA+ (Cas9+) cells. ( K ) Bar graph showing knockdown efficiency. *p< 0.05, **p<0.01, ****p<0.0001

Journal: bioRxiv

Article Title: Cell-type targeted CRISPR/Cas9 Clock knockdown in mouse VTA dopamine neurons alter sleep, behavior, and cellular excitability

doi: 10.64898/2026.06.03.730017

Figure Lengend Snippet: (A) Mouse clock gene structure with sgRNA target sites in Exons 9, 10, and 16; sgRNA (blue) and PAM (red) sequences indicated. sgRNA target sequence is anti-sense relative to the gene coding sequence. Sanger traces from GFP+ nuclei confirm editing at each site; GFP- traces not shown. ( B-D ) Indel distributions for Clock sgRNAs #1-#3 from in vivo virally-transduced nuclei as pie charts and scatter plots of individual editing efficiencies. sgRNA #3 achieved 69% editing efficiency. ( E ) In situ hybridization quantifying Clock mRNA in Cas9-expressing VTA neurons. ( F ) Representative fluorescence images for Cas9 (green), DAT (red) and Clock (cyan). Scale bar = 100 μm. ( G ) Violin plot quantifying Clock mRNA levels in Cas9-expressing cells. Clock-targeted sgRNA significantly reduced mRNA relative to Rosa26 control. ( H ) Experimental design for immunohistochemistry (IHC). Virus expressing Cas9 and sgRNAs targeting Clock (C3 or C2+3) was injected at different titers (low: 5 × 10¹¹, high: 5 × 10¹²). After 4 weeks, brain sections were processed for IHC. (I ) Representative IHC images showing Clock (red), and HA-tag (Cas9+, magenta). Scale bar = 100 μm. ( J ) Clock intensity in HA+ (Cas9+) cells. ( K ) Bar graph showing knockdown efficiency. *p< 0.05, **p<0.01, ****p<0.0001

Article Snippet: Correct insertion of sgRNA sequences was confirmed by Sanger sequencing (Plasmidsaurus).

Techniques: Sequencing, In Vivo, In Situ Hybridization, Expressing, Fluorescence, Control, Immunohistochemistry, Virus, Injection, Knockdown